Medications Influencing Serum Cystatin C Independent of Measured Glomerular Filtration Rate

BACKGROUND: Serum cystatin C is influenced by factors beyond glomerular filtration rate (GFR), and several medications have been hypothesized to alter its generation. Whether reported associations reflect effects on cystatin C independent of measured GFR (mGFR) or confounding by illness remains unclear. METHODS: We studied 5595 adults who underwent outpatient cystatin C (and creatinine) testing with mGFR determination using iohexol clearance in Stockholm healthcare. Associations between eight candidate medication classes and cystatin C were assessed using both inter- and intra-individual analyses, sequentially adjusting for mGFR, clinical variables, and ongoing medications. We further evaluated the effect of these medications on cystatin C-based eGFR (eGFRcys) bias compared with serum creatinine-based (eGFRcr) and combined (eGFRcr-cys) equations. RESULTS: After adjustment for mGFR and confounders, use of systemic glucocorticoids, opioids and loop diuretics was associated with higher cystatin C. The magnitude of increase was potentially clinically meaningful for glucocorticoid use, particularly for greater estimated daily dose categories, whereas the smaller increases observed with opioid and loop diuretic use likely reflect clinically non-meaningful effects. No associations were observed for use of allopurinol, immunosuppressants, thyroid hormone analogues, or antipsychotics, or for paracetamol after adjustment for concomitant medications. eGFRcys underestimated mGFR more in users than in non-users, while eGFRcr overestimated mGFR similarly in users and non-users. eGFRcr-cys provided the least biased GFR estimates. CONCLUSIONS: This study suggests that systemic glucocorticoids, opioids and loop diuretics may increase cystatin C independent of mGFR. Use of eGFRcr-cys was consistently more accurate than either eGFRcr or eGFRcys alone in patients using these treatments.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2026-04-17
DOI
https://doi.org/10.1681/asn.0000001108
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medications Influencing Serum Cystatin C Independent of Measured Glomerular Filtration Rate

Anne‐Laure Faucon, Antoine Créon, Lesley Inker, Edouard L. Fu et al.
Journal of the American Society of Nephrology
Chronic Kidney Disease and Diabetes
article

Medications Influencing Serum Cystatin C Independent of Measured Glomerular Filtration Rate

Anne‐Laure Faucon, Antoine Créon, Lesley Inker, Edouard L. Fu, Andrew S. Levey, Morgan E. Grams, William A. Russel, Aurora Caldinelli, Juan Jesus Carrera, Rik Olde Engberink
article en

Abstract

BACKGROUND: Serum cystatin C is influenced by factors beyond glomerular filtration rate (GFR), and several medications have been hypothesized to alter its generation. Whether reported associations reflect effects on cystatin C independent of measured GFR (mGFR) or confounding by illness remains unclear. METHODS: We studied 5595 adults who underwent outpatient cystatin C (and creatinine) testing with mGFR determination using iohexol clearance in Stockholm healthcare. Associations between eight candidate medication classes and cystatin C were assessed using both inter- and intra-individual analyses, sequentially adjusting for mGFR, clinical variables, and ongoing medications. We further evaluated the effect of these medications on cystatin C-based eGFR (eGFRcys) bias compared with serum creatinine-based (eGFRcr) and combined (eGFRcr-cys) equations. RESULTS: After adjustment for mGFR and confounders, use of systemic glucocorticoids, opioids and loop diuretics was associated with higher cystatin C. The magnitude of increase was potentially clinically meaningful for glucocorticoid use, particularly for greater estimated daily dose categories, whereas the smaller increases observed with opioid and loop diuretic use likely reflect clinically non-meaningful effects. No associations were observed for use of allopurinol, immunosuppressants, thyroid hormone analogues, or antipsychotics, or for paracetamol after adjustment for concomitant medications. eGFRcys underestimated mGFR more in users than in non-users, while eGFRcr overestimated mGFR similarly in users and non-users. eGFRcr-cys provided the least biased GFR estimates. CONCLUSIONS: This study suggests that systemic glucocorticoids, opioids and loop diuretics may increase cystatin C independent of mGFR. Use of eGFRcr-cys was consistently more accurate than either eGFRcr or eGFRcys alone in patients using these treatments.

Journal of the American Society of Nephrology
Tufts Medical Center (US), Leiden University Medical Center (NL), Karolinska Institutet (SE), Amsterdam University Medical Centers (NL), New York University (US)
Good health and well-being
Openalex Percentile: Top 20%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.